Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05207709
PHASE3

Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype

Sponsor: SOLTI Breast Cancer Research Group

View on ClinicalTrials.gov

Summary

HARMONIA is an international, multicenter, randomized, open-label and phase III study. The primary objective of this study is to demonstrate that the combination of ribociclib with endocrine therapy (letrozole or fulvestrant) is superior to palbociclib with endocrine therapy (letrozole or fulvestrant) in prolonging progression-free survival in patients with advanced HR+/HER2- and HER2-E breast cancer. The study will enroll approximately 456 patients with HER2-E disease from approximately 95 sites worldwide. In addition, the HARMONIA trial will include an exploratory cohort of patients with HR+/HER2- and Basal-like disease treated with paclitaxel +/- Tislelizumab. This cohort does not have a predefined sample size and the objective is only exploratory, given the suggested lack of efficacy of the combinations of hormone therapy and CDK4/6 inhibitors in this subgroup of patients. Enrolment into the basal-like cohort will stop once the HER2-E disease cohort is fully enrolled.

Official title: A Phase III, Multicenter, Open-label Study of Ribociclib vs. Palbociclib in Patients With Advanced Hormone Receptor-positive/HER2-negative/HER2-Enriched Breast Cancer - HARMONIA Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

456

Start Date

2022-03-28

Completion Date

2027-03-01

Last Updated

2025-04-29

Healthy Volunteers

No

Interventions

DRUG

Ribociclib + Letrozole OR Fulvestrant

Endocrine Therapy will be selected by the investigator. For premenopausal women and men: LHRH agonist once every 4 weeks

DRUG

Palbociclib + Letrozole OR Fulvestrant

Endocrine Therapy will be selected by the investigator. For premenopausal women and men: LHRH agonist once every 4 weeks

DRUG

Paclitaxel +/- Tislelizumab

Patients in this arm could receive as the first line of therapy

Locations (71)

Morton Plant Hospital

Clearwater, Florida, United States

University of Miami

Coral Gables, Florida, United States

Memorial Regional Hospital

Hollywood, Florida, United States

Mount Sinai Florida

Miami, Florida, United States

Northwestern

Chicago, Illinois, United States

Carle Cancer Center

Urbana, Illinois, United States

University of Kentucky, Markey Cancer Center

Lexington, Kentucky, United States

Sinai of Baltimore

Baltimore, Maryland, United States

Dana Faber Cancer Institute

Boston, Massachusetts, United States

Baptist Memorial Health Care

Oxford, Mississippi, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

Nevada Cancer Research Foundation

Las Vegas, Nevada, United States

NHOH

Londonderry, New Hampshire, United States

Nothwell Health

New York, New York, United States

Montefiore

The Bronx, New York, United States

University of North Carolina Lineberger

Chapel Hill, North Carolina, United States

Novant Health Care

Winston-Salem, North Carolina, United States

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

Dayton Clinical Oncology

Kettering, Ohio, United States

Legacy Good Samaritan Hospital and Medical Cente

Portland, Oregon, United States

Providence Portland Medical Center

Portland, Oregon, United States

The Medical University of South Carolina

Charleston, South Carolina, United States

Upstate Carolina Medical Center

Spartanburg, South Carolina, United States

Edwards Comprehensive Cancer Center

Huntington, Virginia, United States

Bon Secours Memorial Regional Medical Center

Mechanicsville, Virginia, United States

Unv. Wisconsin

Madison, Wisconsin, United States

Hospital Senhora da Oliveira - Guimarães

Creixomil, Portugal

IPO Lisboa

Lisbon, Portugal

Hospital Beatriz Ângelo

Loures, Portugal

Instituto Portugues de Oncologia de Porto Francisco Gentil, EPE

Porto, Portugal

Centro Hospitalar Vila Nova de Gaia

Vila Nova de Gaia, Portugal

Hospital Son Llàtzer

Palma de Mallorca, Balearic Islands, Spain

Institut Català d' Oncologia (ICO Badalona)

Badalona, Barcelona, Spain

Hospital del Mar

Barcelona, Barcelona, Spain

IOB-Institute of Oncology. Hospital Quironsalud Barcelona

Barcelona, Barcelona, Spain

Institut Català d'Oncologia (ICO Hospitalet)

L'Hospitalet de Llobregat, Barcelona, Spain

Hospital General de Catalunya

Sant Cugat del Vallès, Barcelona, Spain

Hospital Universitario de Canarias

Santa Cruz de Tenerife, Canary Islands, Spain

Institut Català d' Oncologia de Girona (ICO Girona)

Girona, Girona, Spain

Hospital Clínico Universitario de A Coruña

A Coruña, La Coruña, Spain

Hospital Clínico Universitario de Santiago CHUS

Santiago de Compostela, La Coruña, Spain

Complejo Asistencial Universitario de León

León, León, Spain

Hospital Universitario de Fuenlabrada

Fuenlabrada, Madrid, Spain

Hospital Universitario Ramón y Cajal

Madrid, Madrid, Spain

Fundación Jiménez Díaz

Madrid, Madrid, Spain

Hospital La Paz

Madrid, Madrid, Spain

Hospital Universitario Virgen de la Arrixaca

El Palmar, Murcia, Spain

Hospital Universitario Morales Meseguer

Murcia, Murcia, Spain

Hospital Quiron Salud Sagrado Corazon Sevilla

Seville, Sevilla, Spain

Hospital Universitario Virgen del Rocio

Seville, Sevilla, Spain

Hospital Clínico Universitario Lozano Blesa

Zaragoza, Zaragoza, Spain

Hospital General Universitario de Alicante

Alicante, Spain

Vall d´Hebron University Hospital

Barcelona, Spain

Hospital Clinic de Barcelona

Barcelona, Spain

Hospital de Basurto

Bilbao, Spain

Complejo Hospitalario San Pedro de Alcántara

Cáceres, Spain

Hospital Universitario Virgen de las Nieves

Granada, Spain

H. Clínico San Cecilio de Granada

Granada, Spain

Hospital Universitario de Gran Canaria Doctor Negrin

Las Palmas, Spain

Hospital Universitari Arnau de Vilanova de Lleida

Lleida, Spain

Hospital Universitario La Princesa

Madrid, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

Centro Integral Oncológico Clara Campal (CIOCC)

Madrid, Spain

Hospital Universitario Puerta de Hierro de Majadahonda

Madrid, Spain

Hospital Virgen de la Victoria

Málaga, Spain

Hospital Sant Joan de Reus

Reus, Spain

Hospital Universitario de Salamanca

Salamanca, Spain

Hospital Universitario Marqués de Valdecilla

Santander, Spain

Hospital Virgen de la Macarena

Seville, Spain

Instituto Valenciano de Oncología (IVO)

Valencia, Spain

Hospital Clinico Universitario de Valencia

Valencia, Spain